Table 2.
Human coronaviruses.
| Coronavirus | Transmission | Disease outcome | Human receptor | Classification | Reference genome NCBI ID (size) |
|---|---|---|---|---|---|
| HCoV-229E | Bats to humans through alpacas, camelids | Mild respiratory symptoms in immuno-compromised patients | Amino-peptidase N | α-CoV | NC_002645.1 (27,317 bp) |
| HCoV-NL63 | Bats to humans through an unknown intermediate | Mild respiratory symptoms in immuno-compromised patients | Angiotensin- converting enzyme 2, Heparan sulfate | α-CoV | NC_005831 (27,553 bp) |
| HCoV-OC43 | Rodents to humans through cattle | Mild respiratory symptoms in immuno-compromised patients | 9-O-acetylsialic acids | β-CoV | NC_006213.1 (30,741 bp) |
| SARS-CoV | Bats to humans through wild animals, palm civets | Acute pneumonia and respiratory disease | Angiotensin- converting enzyme 2, C-type lectin, Pulmonary surfactant protein D |
β-CoV | NC_004718.3 (29,751 bp) |
| MERS-CoV | Bats to humans through dromedary camels | Acute pneumonia and respiratory disease | Dipeptidyl-peptidase 4, Sialic acid | β-CoV | NC_038,294 (30,111 bp) |
| HCoV-HKU1 | Rodents to humans through an unknown intermediate | Mild respiratory symptoms in immunocompromised patients | 9-O-acetylsialic acid | β-CoV | NC_006577.2 (29,926 bp) |
| SARS-CoV-2 | Bats to humans possibly through pangolins | Acute pneumonia and respiratory disease | Angiotensin- converting enzyme 2 | β-CoV | NC_045512.2 (29,903 bp) |